跳至主要内容
临床试验/NCT03577873
NCT03577873已完成不适用

Randomized Controlled Trial on Necessity of Cholecystectomy for Patients With Bile Duct Stones Combined With Gallbladder Stones After Clearance of Stones

First People's Hospital of Hangzhou1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2017年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
128
试验地点
1
主要终点
biliary events

研究概览

简要总结

To discuss necessity of cholecystectomy for patients with stones in their bile ducts and gallbladders in the absence of absolute operation indications of cholecystectomy after clearance of bile duct stones with ERCP.

详细描述

Cholecystectomy was recommended for patients with stones in their bile ducts and gallbladders in European and American countries after clearance of bile duct stones with ERCP, which reduced the incidence of biliary events. However, some researches showed that the incidence of biliary events was not reduced but increased.The purpose of this study is to discuss the necessity of cholecystectomy for patients with stones in their bile ducts and gallbladders in the absence of absolute operation indications of cholecystectomy after clearance of bile duct stones with ERCP.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Obtention of a written informed consent; Clinical diagnosis of gallbladder stones and common bile duct stones; No absolute operation indications of cholecystectomy

排除标准

  • Intrahepatic stones; Malignant tumor disease ;

研究组 & 干预措施

gallbladder preserved

Placebo Comparator

Patients with stones in their bile ducts and gallbladders will keep gallbladders in stay after clearance of bile duct stones with ERCP.

干预措施: gallbladder preserved (Other)

cholecystectomy

Experimental

Patients with stones in their bile ducts and gallbladders will undergo cholecystectomy after clearance of bile duct stones with ERCP.

干预措施: cholecystectomy (Procedure)

结局指标

主要结局

biliary events

时间窗: 12 months

The incidence of biliary events will be compared in the two groups.

次要结局

  • adverse events(12 months)

研究者

发起方
First People's Hospital of Hangzhou
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jianfeng Yang

Deputy director

First People's Hospital of Hangzhou

研究点 (1)

Loading locations...

相似试验